Evidence map›Paper›PMID 39576760›Full record

ArticlePloS one2024

Causal debiasing for unknown bias in histopathology-A colon cancer use case.

Ramón L Correa-Medero, Rish Pai, Kingsley Ebare, Daniel D Buchanan, Mark A Jenkins, Amanda I Phipps, Polly A Newcomb, Steven Gallinger, Robert Grant, Loic Le Marchand and 1 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ramón L Correa-MederoSchool of Computing And Augmented Intelligence Arizona State University, Phoenix, Arziona, United States of America.ORCID 0000-0003-2247-7777
Rish PaiDepartment Of Pathology Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
Kingsley EbareDepartment Of Pathology Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
Daniel D BuchananColorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
Mark A JenkinsUniversity of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
Amanda I PhippsPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Polly A NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Steven GallingerLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Robert GrantLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Loic Le MarchandDepartment of Epidemiology, University of Hawaii, Honolulu, Hawaii, United States of America.
Imon BanerjeeSchool of Computing And Augmented Intelligence Arizona State University, Phoenix, Arziona, United States of America.ORCID 0000-0002-3327-8004

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
NCI NIH HHS U01 CA167551
6 · The paper itself

Abstract

Advancement of AI has opened new possibility for accurate diagnosis and prognosis using digital histopathology slides which not only saves hours of expert effort but also makes the estimation more standardized and accurate. However, preserving the AI model performance on the external sites is an extremely challenging problem in the histopathology domain which is primarily due to the difference in data acquisition and/or sampling bias. Although, AI models can also learn spurious correlation, they provide unequal performance across validation population. While it is crucial to detect and remove the bias from the AI model before the clinical application, the cause of the bias is often unknown. We proposed a Causal Survival model that can reduce the effect of unknown bias by leveraging the causal reasoning framework. We use the model to predict recurrence-free survival for the colorectal cancer patients using quantitative histopathology features from seven geographically distributed sites and achieve equalized performance compared to the baseline traditional Cox Proportional Hazards and DeepSurvival model. Through ablation study, we demonstrated benefit of novel addition of latent probability adjustment and auxiliary losses. Although detection of cause of unknown bias is unsolved, we proposed a causal debiasing solution to reduce the bias and improve the AI model generalizibility on the histopathology domain across sites. Open-source codebase for the model training can be accessed from https://github.com/ramon349/fair_survival.git.

Indexed as

Colonic NeoplasmsBiasDisease-Free SurvivalFemaleHumansMalePrognosisProportional Hazards Models

Identifiers

PMID39576760
PMCPMC11584097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.